Summary
Latest filing:
Faisal Mehmud is Chief Medical Officer of Medicus Pharma Ltd. (MDCX). 4 SEC Form 4 filings on record going back to 2025, most recently on 8 September 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Faisal Mehmud has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Faisal Mehmud's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $199.99M of TYRA open-market activity in the last 12 months
- Catalyst4, Inc. - $191.21M of MPLT open-market activity in the last 12 months
- John Oyler - $189.61M of ONC open-market activity in the last 12 months
- Michael Benkowitz - $174.13M of UTHR open-market activity in the last 12 months
- BVF PARTNERS L P - $173.67M of KYMR open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M of KYMR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Faisal Mehmud?
Faisal Mehmud is a corporate insider, tracked as Chief Medical Officer of Medicus Pharma Ltd. (MDCX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Faisal Mehmud submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Faisal Mehmud's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Faisal Mehmud and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
